Vildagliptin is cost-effective in real-world: economic evaluation evidence from EDGE study

被引：0
|
作者：
Partha, G. [1 ]
Agrawal, R. [1 ]
Paldanius, P. M. [2 ]
Viana, R. [2 ]
机构：
[1] Novartis Healthcare Pvt Ltd, Hyderabad, Andhra Pradesh, India
[2] Novartis Pharma AG, Basel, Switzerland
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
993
引用
收藏
页码：S481 / S481
页数：1
相关论文
共 50 条
  • [21] Finasteride versus dutasteride: A real-world economic evaluation
    Fenter, Thomas C.
    Runken, M. Chris
    Black, Libby
    Eaddy, Michael
    AMERICAN JOURNAL OF MANAGED CARE, 2007, 13 (01): : S23 - S27
  • [22] Starting biologic treatment sequences for plaque psoriasis with ustekinumab or adalimumab is the most cost-effective: a cost-utility analysis based on 10 years of Dutch real-world evidence from BioCAPTURE
    Klijn, S.
    van den Reek, J.
    van de Wetering, G.
    van der Kolk, A.
    de Jong, E.
    Kievit, W.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E292 - E293
  • [23] Study Verifies Value of Real-World Evidence
    Caruso, Catherine
    CANCER DISCOVERY, 2019, 9 (07) : 819 - 819
  • [24] Surveillance for hepatocellular carcinoma is cost-effective in Australia: Evidence from a microsimulation study
    Nguyen, A. L. T.
    Si, L.
    Lubel, J.
    Shackel, N.
    Yee, K. C.
    Wilson, M.
    Bradshaw, J.
    Hardy, K.
    Palmer, A.
    Blizzard, L.
    De Graaff, B.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 99 - 99
  • [25] Are drug-eluting stents cost-effective when compared with bare-metal stents in a real-world setting?
    Moussa, I
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (04): : 192 - 193
  • [26] Are drug-eluting stents cost-effective when compared with bare-metal stents in a real-world setting?
    Issam Moussa
    Nature Clinical Practice Cardiovascular Medicine, 2006, 3 : 192 - 193
  • [27] Weight maintenance on cost-effective antiobesity medications after 1 year of GLP-1 receptor agonist therapy: a real-world study
    Paddu, Nina U.
    Lawrence, Brianna
    Wong, Sydnee
    Poon, Sabrina J.
    Srivastava, Gitanjali
    OBESITY, 2024, 32 (12) : 2255 - 2263
  • [28] Real-world design diversity: A case study on cost
    Kanoun, K
    IEEE SOFTWARE, 2001, 18 (04) : 29 - +
  • [29] Economic Burden of Parkinson’s Disease: A Multinational, Real-World, Cost-of-Illness Study
    K. Ray Chaudhuri
    Jean-Philippe Azulay
    Per Odin
    Susanna Lindvall
    Josefa Domingos
    Ali Alobaidi
    Prasanna L. Kandukuri
    Vivek S. Chaudhari
    Juan Carlos Parra
    Toru Yamazaki
    Julia Oddsdottir
    Jack Wright
    Pablo Martinez-Martin
    Drugs - Real World Outcomes, 2024, 11 : 1 - 11
  • [30] Economic Burden of Parkinson's Disease: A Multinational, Real-World, Cost-of-Illness Study
    Chaudhuri, K. Ray
    Azulay, Jean-Philippe
    Odin, Per
    Lindvall, Susanna
    Domingos, Josefa
    Alobaidi, Ali
    Kandukuri, Prasanna L.
    Chaudhari, Vivek S.
    Parra, Juan Carlos
    Yamazaki, Toru
    Oddsdottir, Julia
    Wright, Jack
    Martinez-Martin, Pablo
    DRUGS-REAL WORLD OUTCOMES, 2024, 11 (01) : 1 - 11
12345